Profiles: Difference between revisions

Revision as of 20:14, 21 November 2016

Profiles published here have completed one of the QIBA Profile Stages of development and been approved by their Biomarker Committee.

How to use QIBA Profiles
QIBA Profile Template shows the structure, rationale and content of a Profile (show All Markup to see guidance in the Word comments)
Committees lists Biomarker Committees developing profiles which may link to DRAFT documents in progress for the next stage.
Profile Conformance describes how sites and products claim conformance to a Profile.

@@ Line 2: / Line 2: @@
 Profiles published here have completed one of the [[QIBA Profile Stages]] of development and been approved by their [[Committees|Biomarker Committee]].
-===[[QIBA_Profile_Stages#Stage_3:_Technically_Confirmed|Stage 3]]: Technically Confirmed===
+===[[QIBA_Profile_Stages#Stage_3:_Technically_Confirmed|Stage 3]]: Technically Confirmed Profiles===
 * [[Media:QIBA FDG-PET Profile v104 06Nov2013.doc|FDG-PET/CT for Response to Cancer Therapy 2013-11-06]] ?
-===[[QIBA_Profile_Stages#Stage_1:_Public_Comment|Stage 2]]: Consensus (Publicly Reviewed)===
+===[[QIBA_Profile_Stages#Stage_1:_Public_Comment|Stage 2]]: Consensus Profiles===
 * [[Media:QIBA_CVol_TumorVolumeChangeProfile_Consensus-20161121.pdf| CT Tumor Volumetry for Advanced Disease 2016-11-21]]
-===[[QIBA_Profile_Stages#Stage_1:_Public_Comment|Stage 1]]: Public Comment===
+===[[QIBA_Profile_Stages#Stage_1:_Public_Comment|Stage 1]]: Public Comment Profiles===
 * [[Media:DCEMRIProfile v1 6-20111213.pdf|DCE-MRI Quantification 2011-12-13]] (''Public Comment ended Feb 2012'')